Form 4: Akero Therapeutics CEO Gifts Shares

Akero Therapeutics President and CEO, Andrew Cheng, reported gifting 14,739 shares of common stock to a 501(c)(3) charitable organization.

Summary

• Andrew Cheng, President and CEO, and a Director of Akero Therapeutics, Inc. (AKRO), reported a transaction involving the company's common stock.
• On November 12, 2025, Cheng disposed of 14,739 shares of Common Stock.
• The disposition was a bona fide charitable gift to a 501(c)(3) organization, with a transaction price of $0 per share.
• Following this transaction, Andrew Cheng beneficially owns 511,375 shares of Akero Therapeutics Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports a charitable gift of shares by an insider, which is a neutral event regarding the company's operational or financial performance.

Positives

• The transaction represents a charitable contribution by a key executive, potentially reflecting personal philanthropy.
• The reporting person explicitly stated no pecuniary interest in the recipient 501(c)(3) organization.

Negatives

• A reduction in direct insider ownership, though for a charitable purpose.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports a personal insider transaction and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: A very minor reduction in insider ownership, unlikely to have a material impact on the company's valuation or operations.
• Charitable Organization: Receives a donation of 14,739 shares of Akero Therapeutics common stock.

Key Dates

Keywords

Akero Therapeutics, AKRO, Andrew Cheng, Insider transaction, Form 4, Charitable gift, Common stock, CEO, Director